Number of studies: k = 17
Number of pairwise comparisons: m = 23
Number of observations: o = 17081
Number of treatments: n = 9
Number of designs: d = 9

Common effects model (Mantel-Haenszel method)

Treatment estimate (sm = 'OR', comparison: other treatments vs 'placebo'):
                 OR            95%-CI     z p-value
celecoxib    0.8552 [0.5814;  1.2580] -0.79  0.4269
lasmiditan   1.1340 [0.9573;  1.3432]  1.45  0.1457
paracetamol  6.4000 [1.1241; 36.4373]  2.09  0.0365
placebo           .                 .     .       .
rimegepant   1.1103 [0.8853;  1.3924]  0.91  0.3652
rizatriptan  0.8470 [0.6101;  1.1759] -0.99  0.3213
sumatriptan  0.9610 [0.6975;  1.3241] -0.24  0.8078
ubrogepant   1.2092 [1.0191;  1.4348]  2.18  0.0295
zolmitriptan 0.9280 [0.6268;  1.3740] -0.37  0.7092

Test of inconsistency (between designs):
   Q d.f. p-value
 6.2    4  0.1848

A total of 9 treatments are included in the network.
A total of 17 studies are included in this analysis.
A total of 17081 participants are included in this analysis, with 2495 events (14.61%).
Estimated heterogeneity tau-squared: NA.
Global test for inconsistency, p-value 0.18481 (Q=6, d.o.f. 4)

The following studies were included in this analysis: 0462-039 1996 Ashina 2021 Croop 2019 Dodick 2019 FÃ¤rkkila 2012 Geraud 2000 Kuca 2018 Lipton 2019a Lipton 2019b Lipton 2019c Lipton 2021 Marcus 2014 Sakai 2021 Tfelt-Hansen 1998 Toledano 2021 Voss 2016 Yu 2023.

File created on 2023-05-27.
